NSE BSE
rossari biotech limited stock

ROSSARI BIOTECH LIMITED Share Price

- - (%)
- NSE: ROSSARI

ROSSARI BIOTECH LIMITED Share Price Update

As of the latest trading session, ROSSARI BIOTECH LIMITED share price is currently at 821.35, which is down by -1.85 from its previous closing. Today, the stock has fluctuated between 808.50 and 830.00. Over the past year, ROSSARI BIOTECH LIMITED has achieved a return of -5.00 %. In the last month alone, the return has been 7.65 %. Read More...

ROSSARI BIOTECH LIMITED Performance

Day Range

Low808.50 High830.00
821.35

52 Week Range

Low 656.95 High 903.85
821.35

ROSSARI BIOTECH LIMITED Share Price

19410

543213

ROSSARI

img img img img
No Data Available

Open Price

830.00

Prev. Close

823.20

Volume (Shares)

108493.00

Total traded value

891.10

Upper Circuit

987.80

Lower Circuit

658.60

Note: The current prices & values are delayed, Login to your account for live updates.

ROSSARI BIOTECH LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 4530.19
PE Ratio (TTM) 45.60
Book Value / Share 173.82
Beta 0.46
ROE 8.69%
EPS (TTM) 18.04
Dividend Yield 0.06%
Net Profit Qtr (Cr) 26.17

ROSSARI BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 313.80
Operating Expense 280.40
Net Profit 26.17
Net Profit Margin (%) 8.33
Earnings Per Share (EPS) 4.74
EBITDA 43.07
Effective Tax Rate (%) 24.69
Particulars DEC 2023 (Values in Cr)
Revenue 298.75
Operating Expense 266.08
Net Profit 25.54
Net Profit Margin (%) 8.54
Earnings Per Share (EPS) 4.62
EBITDA 43.26
Effective Tax Rate (%) 26.60
Particulars SEP 2023 (Values in Cr)
Revenue 332.01
Operating Expense 298.47
Net Profit 26.38
Net Profit Margin (%) 7.94
Earnings Per Share (EPS) 4.78
EBITDA 44.30
Effective Tax Rate (%) 25.69
Particulars JUN 2023 (Values in Cr)
Revenue 258.34
Operating Expense 230.60
Net Profit 21.56
Net Profit Margin (%) 8.34
Earnings Per Share (EPS) 3.91
EBITDA 36.48
Effective Tax Rate (%) 25.88
Particulars MAR 2023 (Values in Cr)
Revenue 263.64
Operating Expense 235.73
Net Profit 23.14
Net Profit Margin (%) 8.77
Earnings Per Share (EPS) 4.20
EBITDA 38.11
Effective Tax Rate (%) 23.45
Particulars MAR 2024 (Values in Cr)
Revenue 1202.91
Operating Expense 1075.55
Net Profit 99.65
Net Profit Margin (%) 8.28
Earnings Per Share (EPS) 18.05
EBITDA 168.01
Effective Tax Rate (%) 25.71
Particulars MAR 2023 (Values in Cr)
Revenue 975.17
Operating Expense 883.13
Net Profit 71.39
Net Profit Margin (%) 7.32
Earnings Per Share (EPS) 12.95
EBITDA 126.25
Effective Tax Rate (%) 25.36
Particulars MAR 2022 (Values in Cr)
Revenue 1072.84
Operating Expense 978.87
Net Profit 79.47
Net Profit Margin (%) 7.40
Earnings Per Share (EPS) 14.49
EBITDA 135.50
Effective Tax Rate (%) 25.50
Particulars MAR 2021 (Values in Cr)
Revenue 690.41
Operating Expense 594.14
Net Profit 79.10
Net Profit Margin (%) 11.45
Earnings Per Share (EPS) 15.34
EBITDA 131.06
Effective Tax Rate (%) 25.37
Particulars MAR 2020 (Values in Cr)
Revenue 600.09
Operating Expense 515.62
Net Profit 65.52
Net Profit Margin (%) 10.91
Earnings Per Share (EPS) 13.48
EBITDA 108.64
Effective Tax Rate (%) 25.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 165.93
ROE % 12.47
ROCE % 17.51
Total Debt to Total Equity 0.05
EBITDA Margin 13.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 146.25
ROE % 16.10
ROCE % 22.71
Total Debt to Total Equity 0.01
EBITDA Margin 13.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.72
ROE % 23.02
ROCE % 28.71
Total Debt to Total Equity 0.10
EBITDA Margin 18.70
Particulars MAR 2020 (Values in Cr)
Book Value / Share 56.48
ROE % 31.79
ROCE % 37.43
Total Debt to Total Equity 0.18
EBITDA Margin 18.04
Particulars MAR 2019 (Values in Cr)
Book Value / Share 56.28
ROE % 36.90
ROCE % 49.79
Total Debt to Total Equity 0.06
EBITDA Margin 15.20
Particulars MAR 2023 (Values in Cr)
Book Value / Share 155.69
ROE % 8.69
ROCE % 11.72
Total Debt to Total Equity 0.04
EBITDA Margin 12.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 142.50
ROE % 13.37
ROCE % 18.34
Total Debt to Total Equity 0.00
EBITDA Margin 12.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 77.88
ROE % 23.00
ROCE % 28.78
Total Debt to Total Equity 0.10
EBITDA Margin 18.98
Particulars MAR 2020 (Values in Cr)
Book Value / Share 55.85
ROE % 32.45
ROCE % 37.97
Total Debt to Total Equity 0.19
EBITDA Margin 18.10
Particulars MAR 2019 (Values in Cr)
Book Value / Share 54.70
ROE % 43.64
ROCE % 54.29
Total Debt to Total Equity 0.15
EBITDA Margin 15.30
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 124.57
Total Assets 1367.56
Total Liabilities 1367.56
Total Equity 915.16
Share Outstanding 55155486
Price to Book Ratio 3.82
Return on Assets (%) 7.84
Return on Capital (%) 10.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 52.35
Total Assets 1256.72
Total Liabilities 1256.72
Total Equity 805.16
Share Outstanding 55056386
Price to Book Ratio 6.41
Return on Assets (%) 7.77
Return on Capital (%) 12.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 88.26
Total Assets 561.34
Total Liabilities 561.34
Total Equity 408.77
Share Outstanding 51929390
Price to Book Ratio 13.32
Return on Assets (%) 14.29
Return on Capital (%) 19.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 127.23
Total Assets 471.51
Total Liabilities 471.51
Total Equity 286.67
Share Outstanding 50752920
Price to Book Ratio 0.00
Return on Assets (%) 13.83
Return on Capital (%) 18.77
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 6.00
Total Assets 249.84
Total Liabilities 249.84
Total Equity 123.81
Share Outstanding 22000000
Price to Book Ratio 0.00
Return on Assets (%) 18.28
Return on Capital (%) 35.76
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 80.79
Total Assets 1125.66
Total Liabilities 1125.66
Total Equity 858.69
Share Outstanding 55155486
Price to Book Ratio 3.82
Return on Assets (%) 6.34
Return on Capital (%) 7.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 34.81
Total Assets 925.93
Total Liabilities 925.93
Total Equity 784.52
Share Outstanding 55056386
Price to Book Ratio 6.41
Return on Assets (%) 8.58
Return on Capital (%) 10.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 85.98
Total Assets 544.35
Total Liabilities 544.35
Total Equity 404.44
Share Outstanding 51929390
Price to Book Ratio 13.32
Return on Assets (%) 14.53
Return on Capital (%) 19.56
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 127.20
Total Assets 468.28
Total Liabilities 468.28
Total Equity 283.47
Share Outstanding 50752920
Price to Book Ratio 0.00
Return on Assets (%) 13.99
Return on Capital (%) 19.02
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 5.98
Total Assets 248.48
Total Liabilities 248.48
Total Equity 120.33
Share Outstanding 22000000
Price to Book Ratio 0.00
Return on Assets (%) 18.42
Return on Capital (%) 36.3
Particulars MAR 2023 (Values in Cr)
Net Income 144.21
Cash from Operations 200.17
Cash from Investing -180.89
Cash from Financing 60.85
Net change in Cash 32.35
Free Cash Flow 233.04
Particulars MAR 2022 (Values in Cr)
Net Income 136.27
Cash from Operations 79.48
Cash from Investing -298.87
Cash from Financing 291.79
Net change in Cash 22.26
Free Cash Flow 117.70
Particulars MAR 2021 (Values in Cr)
Net Income 106.83
Cash from Operations 79.11
Cash from Investing -37.17
Cash from Financing -24.59
Net change in Cash -14.00
Free Cash Flow 137.19
Particulars MAR 2020 (Values in Cr)
Net Income 88.05
Cash from Operations 76.97
Cash from Investing -190.30
Cash from Financing 156.94
Net change in Cash 23.47
Free Cash Flow 152.94
Particulars MAR 2019 (Values in Cr)
Net Income 63.39
Cash from Operations 91.54
Cash from Investing -36.42
Cash from Financing -29.15
Net change in Cash 5.60
Free Cash Flow 135.53
Particulars MAR 2023 (Values in Cr)
Net Income 95.64
Cash from Operations 138.67
Cash from Investing -160.58
Cash from Financing 61.20
Net change in Cash 14.28
Free Cash Flow 160.12
Particulars MAR 2022 (Values in Cr)
Net Income 106.68
Cash from Operations 57.34
Cash from Investing -318.11
Cash from Financing 296.91
Net change in Cash 11.91
Free Cash Flow 89.79
Particulars MAR 2021 (Values in Cr)
Net Income 105.99
Cash from Operations 83.02
Cash from Investing -36.99
Cash from Financing -29.45
Net change in Cash -14.36
Free Cash Flow 141.00
Particulars MAR 2020 (Values in Cr)
Net Income 88.10
Cash from Operations 75.89
Cash from Investing -187.24
Cash from Financing 154.96
Net change in Cash 23.46
Free Cash Flow 151.86
Particulars MAR 2019 (Values in Cr)
Net Income 63.45
Cash from Operations 91.87
Cash from Investing -40.11
Cash from Financing -25.82
Net change in Cash 5.60
Free Cash Flow 135.89
Company Name Price P/E P/B Market Cap 52 Week Low/High
ROSSARI BIOTECH LIMITED 822.70 34.77 4.33 4545.21 657.80 / 903.45
ATUL LTD 7052.10 66.84 4.05 20762.62 5183.10 / 7586.95
BASF INDIA LTD 5587.00 43.03 7.50 24186.12 2421.35 / 5880.00
ORIENTAL AROMATICS LTD 430.80 158.97 2.29 1449.80 296.65 / 502.00
DEEPAK FERTILIZERS & PETR 781.60 22.30 1.82 9866.75 453.20 / 797.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ROSSARI BIOTECH LIMITED 822.70 45.60 4.73 4545.21 657.80 / 903.45
ADVANCE PETROCHEMICALS LTD. 273.60 114.00 6.75 24.62 108.30 / 396.15
ATUL LTD 7052.10 55.38 4.07 20762.62 5183.10 / 7586.95
BASF INDIA LTD 5587.00 43.02 7.50 24186.12 2421.35 / 5880.00
BHAGWATI OXYGEN LTD. 45.81 25.74 2.35 10.58 34.51 / 69.05

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 813.40
  • 26 Days 791.10
  • 10 Days 819.70
  • 50 Days 769.00
  • 12 Days 817.50
  • 100 Days 751.80
  • 20 Days 810.20
  • 200 Days 811.00
818.72
PIVOT
First Resistance 833.18
Second Resistance 843.17
Third Resistance 857.63
First Support 808.73
Second Support 794.27
Third Support 784.28
RSI 53.19
MACD 26.38
Commodity Channel Index (CCI) 16.76
ADX 46.61
Williams % R -54.83

Over 1 Month

down

7.65

Over 3 Months

down

13.97

Over 6 Months

down

4.32

Over 1 Year

down

-5.00

Over 3 Years

down

-11.04

Over 5 Years

down

0.00

ROSSARI BIOTECH LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ROSSARI BIOTECH LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
14.37
Promoter Holdings
68.32
FII
4.02
DII
13.27
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Edward Menezes Shareholding of Promoter and Promoter Group 1.611882E7 29.18
Sunil Srinivasan Chari Shareholding of Promoter and Promoter Group 1.608932E7 29.12
Sbi Small Cap Fund Public Shareholding 3158952.0 5.72
Rossari Biotech India Pvt Ltd Shareholding of Promoter and Promoter Group 3016200.0 5.46
Uti Flexi Cap Fund Public Shareholding 2522344.0 4.57
Life Insurance Corporation Of India Public Shareholding 1698392.0 3.07
Canara Robeco Mutual Fund A/c Canara Robeco Small Cap Fund Public Shareholding 1067293.0 1.93
Jyotishna Sunil Chari Shareholding of Promoter and Promoter Group 1000330.0 1.81
Anita Menezes Shareholding of Promoter and Promoter Group 1002630.0 1.81
Icici Lombard General Insurance Company Ltd Public Shareholding 727778.0 1.32
Uti India Dynamic Equity Fund Public Shareholding 642333.0 1.16
Motilal Oswal Small Cap Fund Public Shareholding 584627.0 1.06
Yash Sunil Chari Shareholding of Promoter and Promoter Group 165000.0 0.3
Mikhail Menezes Shareholding of Promoter and Promoter Group 133200.0 0.24
Chari Family Trust - In The Name Of Sunil Srinivasan Chari Shareholding of Promoter and Promoter Group 110000.0 0.2
Menezes Family Trust - In The Name Of Edward Walter Menezes Shareholding of Promoter and Promoter Group 110000.0 0.2

ROSSARI BIOTECH LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-05-24 0.5 Final 2023-05-24 Equity shares 2022-07-07 0.5 Final 2022-07-08 Equity shares 2021-09-08 0.5 Final 2021-09-11 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ROSSARI BIOTECH LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ROSSARI BIOTECH LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Rossari Biotech Ltd?

Answer Field

The share price of Rossari Biotech Ltd for NSE is ₹ 821.35 and for BSE is ₹ 819.65.

What is the Market Cap of Rossari Biotech Ltd?

Answer Field

The market cap of Rossari Biotech Ltd for NSE is ₹ 4,530.19 Cr. and for BSE is ₹ 4,520.81 Cr. as of now.

What is the 52 Week High and Low of Rossari Biotech Ltd?

Answer Field

The 52 Week High and Low of Rossari Biotech Ltd for NSE is ₹ 903.85 and ₹ 656.95 and for BSE is ₹ 903.45 and ₹ 657.80.

How to Buy Rossari Biotech Ltd share?

Answer Field

You can trade in Rossari Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Rossari Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 0.0%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader